Phibro Animal Health Corporation (PAHC)
Pretax margin
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 67,993 | 10,916 | 54,071 | 72,300 | 66,468 |
| Revenue | US$ in thousands | 1,296,220 | 1,017,680 | 977,889 | 942,300 | 833,350 |
| Pretax margin | 5.25% | 1.07% | 5.53% | 7.67% | 7.98% |
June 30, 2025 calculation
Pretax margin = EBT ÷ Revenue
= $67,993K ÷ $1,296,220K
= 5.25%
The pretax margin of Phibro Animal Health Corporation has exhibited a notable downward trend over the observed period from June 30, 2021, to June 30, 2025. Specifically, the pretax margin was 7.98% as of June 30, 2021, reflecting the company's earnings before taxes as a percentage of its revenue. This margin experienced a slight decline to 7.67% by June 30, 2022, indicating a marginal decrease in profitability on a pretax basis. The downward trajectory continued more markedly, with the pretax margin dropping to 5.53% as of June 30, 2023, signifying a reduction in the company's pre-tax profitability. The decline became more pronounced in the subsequent year, with the pretax margin significantly decreasing to 1.07% by June 30, 2024. This suggests a substantial narrowing of earnings relative to revenue, which could be indicative of increasing costs, declining revenues, or other operational challenges. However, there is a partial recovery observed in the final year, with the pretax margin increasing to 5.25% as of June 30, 2025. Overall, the data reveals that Phibro Animal Health Corporation experienced a substantial contraction in pretax profitability during this period, with a potential improvement in the most recent fiscal year.
Peer comparison
Jun 30, 2025